PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

94 hedge funds and large institutions have $334M invested in Phathom Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
–
Holders Change %
0%
% of All Funds
1.63%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
19
Increased
34
Reduced
23
Closed
18
Calls
$1.92M
Puts
$3K
Net Calls
+$1.91M
Net Calls Change
+$450K

Top Buyers

1
FLSM
1
Frazier Life Sciences Management
California
$93.2M
2
DM
2
Deerfield Management
New York
$26.8M
3
6CM
3
683 Capital Management
New York
$18.4M
4
CS
4
Candriam SCA
Luxembourg
$1.24M
5
GKIM
5
GW&K Investment Management
Massachusetts
$6.57M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$10.7M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$0
3
Mirae Asset Global Investments
3
Mirae Asset Global Investments
South Korea
$0
4
EAM
4
Eventide Asset Management
Massachusetts
$0
5
WSL
5
Western Standard LLC
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VM
101
Venator Management
Pennsylvania
– -$211K -25,000 Closed
Renaissance Technologies
102
Renaissance Technologies
New York
– -$203K -24,000 Closed
PP
103
PDT Partners
New York
– -$101K -11,922 Closed
FDCDDQ
104
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$5.06K -600 Closed
ACM
105
Aquatic Capital Management
Illinois
– -$3K -400 Closed
CAPTRUST Financial Advisors
106
CAPTRUST Financial Advisors
North Carolina
– -$1K -99 Closed
1 2 3 4
5